FundingHealthcare & Life Sciences
CARPL.ai raises $10 Mn in Series A funding
By Abha Lohia · Editor ·
Series ADelhi NCRFounded 2018
- CARPL.ai is a healthtech SaaS platform that helps hospitals deploy and manage multiple medical imaging AI applications
- It raised $10 Mn (about ₹96 Cr) in Series A funding led by IFC, with participation from Stellaris Venture Partners
- The company plans to use the funds for global expansion and product development, and to expand beyond radiology into pathology and genomics
What happened
- CARPL.ai raised $10 Mn (about ₹96 Cr) in a Series A funding round.
- The round was led by International Finance Corporation (IFC), the private sector arm of the World Bank Group.
- Existing investor Stellaris Venture Partners also participated, along with undisclosed investors.
- The company will use the funds for product development, expanding sales and delivery teams globally, and strengthening its technology stack.
- It also plans to expand its global partner ecosystem and drive commercial growth across North America, LATAM, Europe, Asia-Pacific, and emerging markets.
- CARPL.ai aims to expand beyond medical imaging into pathology, genomics, and general medicine.
Why it matters
- Medical imaging generates more than 80% of healthcare data, but AI adoption remains fragmented despite over 1,000 FDA-cleared radiology applications.
- The Indian healthtech market is projected to become a $37 Bn opportunity by 2030.
- CARPL.ai was part of the YourStory Tech30 cohort of 2022.
The business
- CARPL.ai is a healthtech SaaS platform that enables hospitals and radiologists to deploy, manage, and monitor multiple medical imaging AI applications through a single interface.
- It is a vendor-neutral platform, allowing healthcare providers to build, test, deploy, and monitor AI applications used in radiology.
- The platform hosts an AI marketplace with more than 300 AI applications from over 100 vendors and partners.
- It integrates deeply with leading PACS (Picture Archiving and Communication System) providers, which store, retrieve, manage, and share medical images like X-rays and MRIs.
- Customers include 30 hospitals and medical centres across North America, Latin America, Europe, UK, Middle East, India, Southeast Asia, and Australia.
- Notable customers include the Singapore government, Clinton Health Access Initiative in India, I-MED Radiology Network (Australia), RadNet (US), Fleury (Brazil), and Medica (UK).
- The company serves four of the five largest private radiology groups globally and government health systems in Brazil, India, Singapore, Spain, and UAE.
- It has 80 employees and offices in Delhi NCR (headquarters), San Francisco Bay Area, and Singapore.
The founders
VM
Vidur Mahajan
CEO- Founded CARPL.ai in 2018 (officially launched in 2021).
- No other background details provided in the facts.
Who put in money
- International Finance Corporation lead — Private sector arm of the World Bank Group.
- Stellaris Venture Partners participated — Existing investor; previously led CARPL.ai's seed round.
In numbers
$10 MnFunding amount · 2026
$6 MnPrevious funding · 2023/2024
300+AI applications on platform · 2026
100+Vendors/partners · 2026
30 hospitals and medical centresCustomers · 2026
80Employees · 2026
What happens next
- Expand beyond medical imaging into pathology, genomics, and general medicine.
- Strengthen technology stack and expand global partner ecosystem.
- Drive commercial growth across North America, LATAM, Europe, Asia-Pacific, and emerging markets.
Earlier rounds
- 2023/2024 · Seed · $6 Mn · led by Stellaris Venture Partners
Words to know
- Series A
- The first significant round of venture capital funding, typically used to scale the business.
- PACS
- Picture Archiving and Communication System – a system used to store, retrieve, manage, and share medical images like X-rays and MRIs.
- Vendor-neutral platform
- A platform that works with products from multiple vendors, allowing users to choose and switch between different AI applications easily.
- FDA-cleared
- Approved by the US Food and Drug Administration for medical use.
The numbers around it
Healthcare & Life Sciences in July 2026: 11 rounds with a disclosed amount, $87.1 million in all; the biggest was Iswarya (Rs 350 crore). Every sector this year →
Other articles talking about it
Inc42 ↗Business Standard ↗Your Story ↗indian-startup-times ↗Indian Startup Times ↗Indian Startup News ↗thesaasnews ↗equitypandit ↗Entrackr ↗entrepreneur.economictimes.indiatimes ↗Inc42 ↗
Terms in this story
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Series A: Series A is usually the first large round a startup raises from venture capital funds, after it has shown that people want what it sells. In India it commonly runs from a few million dollars to about $15 million, or roughly ₹25 crore to over ₹100 crore, with founders selling about 15 to 25 percent, as of November 2026.
- SaaS: SaaS, or software as a service, is software that customers rent for a recurring fee instead of buying once. Revenue is steady and predictable, which investors like. The key numbers are annual recurring revenue (ARR), churn and net revenue retention, and many Indian SaaS firms sell mostly to customers in the United States.
- Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
All startup news on 23 July 2026 →
Is this CARPL.ai? Get your “Featured on StopDown” badge →